Predicting the Response to EGFR Tyrosine Kinase Inhibitor Gefitinib in Head-and-Neck Cancer -- The Carissa GORTEC 2004-02 Study

✍ Scribed by Thariat, J.; Bensadoun, R.; Etienne-Grimaldi, M.; Grall, D.; Penault-Llorca, F.; Dassonville, O.; Cayre, A.; Giraud, P.; Van Obberghen-Schilling, E.; Milano, G.

• Book ID: 122685948
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 61 KB
• Volume: 84
• Category: Article
• ISSN: 0360-3016
• DOI: 10.1016/j.ijrobp.2012.07.059